Analysts: more sales Sartorius

Tomorrow the German company Sartorius will publish its past quarters results. Over the current book year the total revenue will be 1,56 billion euros (consensus estimates). This is rather significant more than 2017's revenue of 1,4 billion euros.

Historical revenues and results Sartorius plus estimates 2018

The analysts expect for 2018 a net profit of 165 million euros. The majority of the analysts expects for this year a profit per share of 2,42 euros. Based on this the price/earnings-ratio is 42,98.

Per share the analysts are expecting a dividend of 0,53 cents per share. Thus the dividend yield equals 0,51 percent. The average dividend yield of the biotech companies is a low 0,5 percent.

Latest estimates around 111 euros

The most recent recommendations for the biotech company are from Nord Landesbank, M.M. Warburg & Co. and Kepler Capital Markets.

Based on the current number of outstanding shares Sartorius's market capitalization 3,56 billion euros. The Sartorius stock was the past 12 months quite volatile. Since last January the stock is even 23 percent higher. This year the stock price moved between 82 and 141 euro. Since 2008 the stock price is almost 3425 percent higher.

At 10.01 the stock trades 0,48 percent higher at 104 euros.

Historical stock prices Sartorius

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.